Today, we will talk about the “Joint Action FOR Rare Diseases” Which is a group of coherent activities on a specific topic that is jointly funded by the European Commission and those EU Member States who decide to participate in it. As a result, a Joint Action has a strong European added value and provides outcomes that offer benefits on the national level.